Indications and management of implantable cardioverter-defibrillator therapy in childhood hypertrophic cardiomyopathy: A position statement from the AEPC Working Group on Basic Science, Genetics and Myocardial Disease and the AEPC Working Group on Cardiac Dysrhythmias and Electrophysiology – ERRATUM

Juan Pablo Kaski; Janneke A.E. Kammeraad; Nico A. Blom; Juha-Matti Happonen; Jan Janousek; Sabine Klaassen; Giuseppe Limongelli; Ingegerd Östman-Smith; Georgia Sarquella Brugada; Lidia Ziolkowska

doi:10.1017/S1047951123004237

Indications and management of implantable cardioverter-defibrillator therapy in childhood hypertrophic cardiomyopathy: A position statement from the AEPC Working Group on Basic Science, Genetics and Myocardial Disease and the AEPC Working Group on Cardiac Dysrhythmias and Electrophysiology – ERRATUM

Published online by Cambridge University Press: 22 January 2024

Juan Pablo Kaski ,

Janneke A.E. Kammeraad ,

Nico A. Blom ,

Juha-Matti Happonen ,

Jan Janousek ,

Sabine Klaassen ,

Giuseppe Limongelli ,

Ingegerd Östman-Smith ,

Georgia Sarquella Brugada and

Lidia Ziolkowska

Article contents

Abstract
References

Rights & Permissions

Abstract

An abstract is not available for this content. As you have access to this content, full HTML content is provided on this page. A PDF of this content is also available in through the ‘Save PDF’ action button.

Information

Type: Erratum
Information: Cardiology in the Young , Volume 34 , Issue 2 , February 2024 , pp. 469

DOI: https://doi.org/10.1017/S1047951123004237 [Opens in a new window]
Creative Commons: This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright: © The Author(s), 2024. Published by Cambridge University Press

The publisher apologises that the final three pages of this article were missing in its initial publication. This article has been updated to include the pages.

References

Kaski, JP, Kammeraad, JAE, Blom, NA, et al. Indications and management of implantable cardioverter-defibrillator therapy in childhood hypertrophic cardiomyopathy: A position statement from the AEPC Working Group on Basic Science, Genetics and Myocardial Disease and the AEPC Working Group on Cardiac Dysrhythmias and Electrophysiology. Cardiology in the Young. 2023;33(5):681–698. doi: 10.1017/S1047951123000872 CrossRef Google Scholar